SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2019–2020
AEFI surveillance in Victoria continues to be robust through the SAEFVIC model and provides confidence in informing the safety profile of vaccines administered in Australia. These data provide a baseline for AEFI surveillance for comparison to the COVID-19 vaccination program commenced in 2021.
Authors
- Georgina Lewis (ORCID: https://orcid.org/0009-0002-2147-7126)
- Emma Roney
- Jim Buttery (ORCID: https://orcid.org/0000-0001-9905-2035)
- Nigel Crawford
- Hazel Clothier
- Jesse Fryk
Institutions
- Royal Children's Hospital (AU)
- Victorian Clinical Genetics Services (AU)
- Murdoch Children's Research Institute (AU)
Publication Details
- Journal
- Communicable Diseases Intelligence
- Published
- 2026-02-23
- DOI
- https://doi.org/10.33321/cdi.2026.50.012
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- State Government of Victoria